ライフサイエンスコーパス: nevi

1 in 44 AGMs from the Caribbean (St. Kitts and Nevis).

2 nment that constrain proliferation of common nevi.

3 the current clinical evaluation of choroidal nevi.

4 21 (4.6%) were melanomas, and 4 (0.9%) were nevi.

5 ifference between DNs and common melanocytic nevi.

6 ere identified at both time points in all 44 nevi.

7 photoreceptor mosaic overlying the choroidal nevi.

8 y melanomas were associated with melanocytic nevi.

9 lities in the retina overlying the choroidal nevi.

10 of keratinocyte dysplasia within dysplastic nevi.

11 stent on a cytomorphologic basis with occult nevi.

12 morphologic features of perianal melanocytic nevi.

13 compared with normal melanocytes and benign nevi.

14 o evaluate the ability to identify choroidal nevi.

15 teledermoscopy for short-term monitoring of nevi.

16 neous melanoma and is also commonly found in nevi.

17 fied, with the most common being intradermal nevi.

18 od, with the greatest risk in large or giant nevi.

19 attern and dermal nests were associated with nevi.

20 short-term monitoring of clinically atypical nevi.

21 teledermoscopy for short-term monitoring of nevi.

22 assifier distinguishing 60 melanomas from 48 nevi.

23 noma, but only after stable growth arrest as nevi.

24 again was higher than that in normal skin or nevi.

25 ntiation of malignant melanoma versus benign nevi.

26 so suggest a potential hormonal influence on nevi.

27 cancer according to the number of cutaneous nevi.

28 introduced term "mosaic RASopathy" for these nevi.

29 74-4,649) per 100,000 women with "very many" nevi.

30 sequencing on five specimens of large-giant nevi.

31 CI, 8.82%-14.76%) for women with 15 or more nevi.

32 for most patients with suspicious choroidal nevi.

33 s in the evaluation of the area of choroidal nevi.

34 lysis to identify morphologically suspicious nevi.

35 toses; and malignant melanomas versus benign nevi.

36 uently develop collagenous connective tissue nevi.

37 elanomas and their adjacent benign precursor nevi.

38 elanoma, multiple primary melanomas, or many nevi.

39 on of melanoma from conventional melanocytic nevi.

40 re derived directly from benign, melanocytic nevi.

41 Indices corresponding to common nevi (0-1), dysplastic nevi (1-4), and melanoma (5-8) we

42 rresponding to common nevi (0-1), dysplastic nevi (1-4), and melanoma (5-8) were significantly differ

43 75 [1.14-6.64]; P = .02), with more than 100 nevi (1.63 [1.02-3.60]; P = .04), or with the diagnosis

44 (1 pingueculum, 1 dermolipoma, 2 melanocytic nevi, 1 melanoma).

45 multivariable-adjusted hazard ratio per five nevi, 1.09, 95% CI, 1.02-1.16 for ER+/progesterone recep

46 confidence interval [CI], 0.98-1.10 for 1-5 nevi; 1.15, 95% CI, 1.00-1.31 for 6-14 nevi, and 1.35, 9

47 Twenty-three lesions were excised (3 nevi, 10 melanomas, 5 squamous cell carcinoma, 2 lymphom

48 Most of the nevi (116 [95.9%]) enlarged at some point during sequent

49 Images from 7 nevi (14%) were suboptimal in quality.

50 sk group 1 [>50 common and/or </= 3 atypical nevi], 2.75 [1.14-6.64]; P = .02), with more than 100 ne

51 psy-proven lesions, including 55 melanocytic nevi, 20 melanomas, 15 basal cell carcinomas, 7 solar le

52 c nevi (67%) compared with 2 of 9 amelanotic nevi (22%).

53 c nevi (78%) compared with 6 of 21 melanotic nevi (29%), and was not significantly related to tumor t

54 8; 95% CI, 1.1-3.1); and at least 4 atypical nevi 5 mm or greater in diameter (OR, 1.9; 95% CI, 1.1-3

55 P = .05) more apparent in 14 of 21 melanotic nevi (67%) compared with 2 of 9 amelanotic nevi (22%).

56 nded bordering vessels were identified in 22 nevi (73%) and were significantly associated with the pr

57 f 477 lesions (119 melanomas [24.9%] and 358 nevi [75.1%]), which were divided into 12 image sets tha

58 reaction using a discovery set of 73 benign nevi, 76 primary cutaneous melanoma, and 11 in-transit m

59 (P = .02) more apparent in 7 of 9 amelanotic nevi (78%) compared with 6 of 21 melanotic nevi (29%), a

60 (34.5%+/-9.8%, P < 0.05) than in benign iris nevi (8.0%+/-1.4%) or normal irides (8.0%+/-1.2%).

61 3-11.01]; P < .01) and high nevi count (>200 nevi) (8.4 [2.14-33.19]; P < .01).

62 A convenience sample of 40 skin lesions (8 nevi, 8 seborrheic keratoses, 7 basal cell carcinomas, 7

63 contributed a total of 51 nevi, of which 44 nevi (86%) were used for the study.

64 82% (95% CI, 8.31%-9.33%) for women with 1-5 nevi, 9.75% (95% CI, 8.48%-11.11%) for women with 6-14 n

65 line to follow-up tissue anchors in 40 of 43 nevi (93%; P < .01) and 42 of 43 nevi (98%; P < .01), re

66 Of 104 choroidal nevi, 97 lesions (93.3%) could be classified into 1 of t

67 A total of 102 nevi (98 patients) were included.

68 in 40 of 43 nevi (93%; P < .01) and 42 of 43 nevi (98%; P < .01), respectively.

69 valence and morphologic features of perianal nevi according to race/ethnicity, sex, and age.

70 levels according to the number of cutaneous nevi among a subgroup of postmenopausal women without po

71 ociation of many total nevi (TN) or atypical nevi (AN) with tumor thickness.

72 mean age, 45.1+/-13.4 years) with choroidal nevi and 14 healthy age-matched volunteers (24 eyes).

73 cases of spitzoid tumors ranging from Spitz nevi and atypical Spitz tumors to spitzoid melanoma.

74 explored the relationships between number of nevi and benign and malignant breast disease risk.

75 of nevogenesis compared with common acquired nevi and differs from prior reports of BN development in

76 These results show that although melanocytic nevi and dysplastic nevi harbor stable genomes with rela

77 ose-response relationships between number of nevi and history of biopsy-confirmed BBD (n = 5,169; ptr

78 and increased nevi and V600K with increased nevi and less freckling (all P < 0.05).

79 component of structural damage in choroidal nevi and may correlate and possibly predict functional v

80 The mouse model also exhibited dermal nevi and melanocytic neoplasms of the central nervous sy

81 d additional regulatory loci and pathways in nevi and melanoma biology.

82 Our data show that benign nevi and melanoma can be differentiated with 97% sensiti

83 asive and metastatic melanoma, compared with nevi and melanoma in situ (P < 0.0001).

84 In large cohorts of nevi and melanoma samples, PDK1 expression was significa

85 MPM images corresponding to dysplastic nevi and melanoma were compared with standard histopatho

86 arrest and tumor suppression in melanocytic nevi and melanoma.

87 5 and p16 IHC analyses on a random series of nevi and melanomas.

88 oliferations such as keratinocytic epidermal nevi and nevus sebaceous result from somatic mosaicism.

89 Most patients with melanoma had few nevi and no AN.

90 han lost, in primary melanomas compared with nevi and normal skin.

91 lia in Spitzoid melanoma compared with Spitz nevi and positions ciliation index as an informative anc

92 Similarly, microarray analyses of benign nevi and primary melanomas from different stages reveale

93 nuclear staining for both proteins in benign nevi and superficial spreading melanoma.

94 dings suggest associations between number of nevi and the risk of premenopausal breast cancer, BBD, a

95 roves our understanding of predisposition to nevi and their potential contribution to melanoma pathog

96 r age, blond/light brown hair, and increased nevi and V600K with increased nevi and less freckling (a

97 xcellent potential for identifying choroidal nevi and was in full agreement with conventional methods

98 Patients with many nevi and without previous melanomas or traits of familia

99 rmed in the validation set (29 melanomas, 25 nevi) and other published sample sets.

100 r 1-5 nevi; 1.15, 95% CI, 1.00-1.31 for 6-14 nevi, and 1.35, 95% CI, 1.04-1.74 for 15 or more nevi; p

101 % (95% CI, 8.48%-11.11%) for women with 6-14 nevi, and 11.4% (95% CI, 8.82%-14.76%) for women with 15

102 rse set of 89 primary invasive melanomas, 73 nevi, and 41 melanocytic proliferations of uncertain mal

103 n of the nestin gene in melanoma compared to nevi, and 5-hmC binding in this region was significantly

104 family history, 59 years for those with many nevi, and 69 years for those with a previous melanoma).

105 nd tissues compared to human melanocytes and nevi, and AMIGO2 silencing in melanoma cells induces G1/

106 or benign iris lesions, including freckles, nevi, and an iris pigment epithelial (IPE) cyst, were im

107 genesis, benign "nevic" metastases, eruptive nevi, and epidermotropic metastatic melanoma.

108 unger age, blond/light brown hair, increased nevi, and less freckling, and NRAS(+) with older age rel

109 tion between malignant melanoma and atypical nevi, and may lead to a substantial reduction in the num

110 Analysis of 25 samples of normal human skin, nevi, and melanomas revealed a positive correlation betw

111 ly higher in primary melanoma, compared with nevi, and was further increased in metastatic melanoma.

112 Nevi are among the strongest risk factors for melanoma.

113 To test the hypothesis that nevi are associated with breast tumor risk, we explored

114 Nevi are important phenotypic risk factors for melanoma

115 fferences between DNs and common melanocytic nevi are not completely understood.

116 sclerosis complex-related connective tissue nevi are not limited to the lower back, and occasionally

117 ow-up is mandatory, especially when multiple nevi are present and these drugs are used in an adjuvant

118 Cutaneous nevi are suggested to be hormone-related.

119 cal genomic breakpoints, indicating that the nevi arose from a single transformed melanocyte and then

120 ched or depleted in melanoma compared to the nevi as a normalization strategy, we developed a model t

121 The propensity to consider more or fewer nevi as having ugly duckling signs was independent of th

122 ligands were abundant in severely dysplastic nevi, as well as in primary and metastatic melanomas.

123 he development of skin hyperpigmentation and nevi, as well as melanoma formation with incomplete pene

124 The number of nevi-associated melanomas increased from 15.5% to 33.3%.

125 image in vivo and noninvasively melanocytic nevi at three different stages: common nevi without dysp

126 ivariable-adjusted odds ratio for every five nevi attenuated from 1.25 (95% CI, 0.89-1.74) to 1.16 (9

127 nd invasive melanoma, dysplastic nevi, Spitz nevi, atypical nevus syndrome, family history of melanom

128 ation from 1991 to 2013 to characterize blue nevi (BN) by patient age at biopsy, location, self-repor

129 mutants were significantly younger, had more nevi but fewer actinic keratoses, were more likely to re

130 = 1.64; 95% confidence interval = 1.18-2.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidenc

131 tes growth arrest of Braf(V600E) melanocytic nevi, but is insufficient for complete progression to me

132 ng increased the identification of choroidal nevi by 27% (406 eyes [5.3%] by NMFP vs 545 eyes [6.9%]

133 abeled UDN and as morphologically suspicious nevi by the 9 dermatologists.

134 ive genes between DNs and common melanocytic nevi by three independent statistical approaches and its

135 s, are distinguished from common melanocytic nevi by variegation in pigmentation and clinical appeara

136 ement of clinically atypical nevi/dysplastic nevi (CAN/DN) is controversial, with few data to guide t

137 mostly asymptomatic, patients with choroidal nevi carry a moderate risk for malignant transformation

138 Most benign nevi carry oncogenic BRAF(V600E) mutations but rarely be

139 d melanoma arising in congenital melanocytic nevi (CMN) is crucial, as patients with PNs most often e

140 mas (CMs), 3 melanomas arising in congenital nevi (CNMs), and 5 spitzoid melanomas (SMs), using vario

141 n was significantly increased in melanocytic nevi compared with melanomas (mean H scores, 254.8 versu

142 icopathologic diagnosis was made in 27.7% of nevi compared with only 10.3% using the standard method.

143 on-focused analyses were used, the number of nevi considered for biopsy was reduced by a factor of 6.

144 in MPM (4.5 [1.83-11.01]; P < .01) and high nevi count (>200 nevi) (8.4 [2.14-33.19]; P < .01).

145 risk, MITF p.E318K is associated with a high nevi count and could play a role in fast-growing melanom

146 in DNA methylomes associated with total body nevi count, incorporating genetic and transcriptomic var

147 The TAT for nevi decreased from 2 days to 1 day, for melanomas from

148 Conjunctival melanoma and nevi demonstrated the same intralesional tortuous patter

149 Both iris melanoma and nevi demonstrated tortuous patterns, distinct from the r

150 anocytic nevi involuted, while the remaining nevi did not change.

151 Nevi displaying a peripheral globular pattern enlarged s

152 Dysplastic nevi (DN) is a strong risk factor for cutaneous malignan

153 biopsy-proven, mild and moderate dysplastic nevi (DN).

154 Dysplastic nevi (DNs), also known as Clark's nevi or atypical moles

155 these distinctive neoplasms.Deep penetrating nevi (DPN) are unusual melanocytic neoplasms with unknow

156 The management of clinically atypical nevi/dysplastic nevi (CAN/DN) is controversial, with few

157 were associated with prominent and atypical nevi elsewhere.

158 Of the 2089 clinical images of nevi from 80 patients (median number of nevi per patient

159 ch the problem of differentiating dysplastic nevi from common melanocytic nevi through a molecular le

160 typic profiles for epidermal and melanocytic nevi from recent studies.

161 es of melanocytic nevi (including dysplastic nevi) from melanoma, we sequenced exomes of melanocytic

162 hough not expressed in benign melanocytes of nevi, GILT and MHC class II expression is induced in mal

163 n the top decile of the cohort or having any nevi greater than 5 mm in diameter.

164 Postmenopausal women with six or more nevi had a 45.5% higher level of free estradiol and a 47

165 cancer risk factors, women with "very many" nevi had a significantly higher breast cancer risk (HR =

166 omen with no nevi, women with more cutaneous nevi had higher risks of breast cancer (multivariable-ad

167 Nevi harbor some of the same oncogene mutations that als

168 hat although melanocytic nevi and dysplastic nevi harbor stable genomes with relatively few alteratio

169 Exome sequencing revealed that dysplastic nevi harbored a substantially lower mutational load than

170 n by BRAF(V600E)-activating mutations, while nevi harboring the same mutations have growth arrest.

171 enotypes including counts of common acquired nevi has not yet been established.

172 While melanocytic nevi have been associated with genetic factors and child

173 n roughly 50% of melanomas and 70% of benign nevi, have improved response rates and survival in patie

174 omas according to patient risk factors: many nevi, history of previous melanoma, and family history o

175 ion-focused analysis and IPCA, and number of nevi identified for biopsy.

176 ls were recognized in over two thirds of the nevi imaged and were significantly associated with previ

177 Retrospective analysis of choroidal nevi imaged with SS OCT and NIR.

178 eciation of intralesional details: Of the 30 nevi imaged, intralesional vessels were apparent in 30 (

179 examination revealed remnants of melanocytic nevi in 103 melanomas (54.2%).

180 ly suggested hypothesis regarding involuting nevi in BRAF inhibitor therapy is correct: Nevi that inv

181 a mutation carrier: total number of atypical nevi in childhood (hazard ratio [HR], 1.21; 95% CI, 1.02

182 nd a correlation between the distribution of nevi in childhood and adulthood and the distribution of

183 Numbers and distribution of melanocytic nevi in childhood are major indicators of the risk of me

184 observational cohort study from the Study of Nevi in Children was conducted from January 1, 2009, to

185 linic, University of Barcelona; and Study of Nevi in Children.

186 le phenotype, development of new melanocytic nevi in older individuals is uncommon and considered wor

187 tray the mutational repertoire of dysplastic nevi in patients with the dysplastic nevus syndrome and

188 histological appearance of connective tissue nevi in patients with TSC.

189 ence and morphologic features of melanocytic nevi in the perianal area.

190 derstanding the growth arrest of melanocytic nevi in vivo termed stable clonal expansion.

191 he method to distinguish between melanocytic nevi in vivo.

192 melanoma, we sequenced exomes of melanocytic nevi including dysplastic nevi (n = 19), followed by a t

193 Additionally, melanocytic nevi including dysplastic nevi showed a significantly lo

194 e the discriminatory profiles of melanocytic nevi (including dysplastic nevi) from melanoma, we seque

195 idence of moderately and severely dysplastic nevi increased from 1.0% to 7.2% and from 0.6% to 1.4%,

196 ely 50% of the existing acquired melanocytic nevi involuted, while the remaining nevi did not change.

197 rtance: The presence of numerous melanocytic nevi is a significant melanoma risk factor, but there ar

198 Monitoring of atypical nevi is an important step in early detection of melanoma

199 The progression of nevi is restrained by multiple tumor-suppressive mechani

200 Number of nevi labeled UDN and morphologically suspicious nevi, sp

201 nt of large and giant congenital melanocytic nevi (lgCMN) relies heavily upon iterative surgical proc

202 intrapatient comparative analysis (IPCA) of nevi may help improve the detection of melanoma.

203 ginning to understand the growth patterns of nevi may improve the ability of physicians to differenti

204 results suggest that the number of cutaneous nevi may reflect plasma hormone levels and predict breas

205 patient was 0.8 among the clinical images of nevi (mean, 1.0; range, 0.48-2.03) and 1.26 among the de

206 expression was increased incrementally from nevi [mean fluorescence intensity (MFI), 48.1; interquar

207 of PEDF in common and dysplastic melanocytic nevi, melanoma in situ, invasive melanoma, and metastati

208 We hypothesized that the number of cutaneous nevi might be a phenotypic marker of plasma hormone leve

209 mes of melanocytic nevi including dysplastic nevi (n = 19), followed by a targeted gene panel (785 ge

210 digital (n = 13) acral skin as well as acral nevi (n = 24) for clinical, histologic, and molecular fe

211 (785 genes) characterization of melanocytic nevi (n = 46) and primary melanomas (n = 42).

212 to discuss treatment options for melanocytic nevi, nevus sebaceus, port-wine stains, and hemangiomas.

213 sures were morphologic features of choroidal nevi obtained with SS-OCT imaging.

214 ence interval = 1.18-2.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidence interval = 0.92-

215 95% confidence interval = 0.92-1.21) or 5-mm nevi (odds ratio = 1.26; 95% confidence interval = 0.94-

216 The same 2089 digital images of the nevi of a sample of 80 patients (mean age, 42 years [ran

217 Perianal nevi of any size, at least 2 mm in diameter, and at leas

218 mimic an IPCA situation, with images of all nevi of each patient shown to the dermatologists, who we

219 riving mutations giving rise to melanomas or nevi of similar growth patterns.

220 [59%] were women) contributed a total of 51 nevi, of which 44 nevi (86%) were used for the study.

221 -1.44; P = .03), the nevus count of atypical nevi on the buttocks (HR, 14.00; 95% CI, 2.94-66.55; P =

222 linical characteristics of connective tissue nevi on the trunk and extremities of patients with tuber

223 Dysplastic nevi (DNs), also known as Clark's nevi or atypical moles, are distinguished from common me

224 nnually thereafter for moderately dysplastic nevi or atypical nevus syndrome; biannually for up to 3

225 ma group when compared with either the Spitz nevi or atypical Spitz tumors groups.

226 on that can occur in the setting of eruptive nevi or epidermotropic melanoma metastases.

227 annually thereafter for severely dysplastic nevi or melanomas in situ; every 3 months for 2 years, b

228 quivocal in situ melanoma without associated nevi or regression was identified using a consecutive sa

229 : annually for mildly dysplastic nevi, Spitz nevi, or solely family history of melanoma; biannually f

230 free testosterone compared to those with no nevi (p for trend = 0.001 for both).

231 , and 1.35, 95% CI, 1.04-1.74 for 15 or more nevi; p for continuous trend = 0.003).

232 and 766 dermoscopic images (median number of nevi per patient, 19 [range, 8-81]), all melanomas were

233 s of nevi from 80 patients (median number of nevi per patient, 26 [range, 8-81]) and 766 dermoscopic

234 ipheral rim of globules (peripheral globular nevi [PGN]) observed with dermoscopy are associated with

235 ons of phenotypic characteristics (freckles, nevi, phenotypic index) and MC1R status with incident am

236 gene in melanocytes reliably produces benign nevi (pigmented 'moles'), yet the same change is the mos

237 Absence of back nevi, presence of many freckles, a sun-sensitive phenoty

238 phenotypic characteristics, absence of back nevi, presence of many freckles, and a sun-sensitive phe

239 Choroidal nevi present distinct patterns according to SS OCT featu

240 melanoma risk among patients with congenital nevi, prospective trials are needed to more accurately a

241 In the multiple choice matching test (n = 43 nevi), readers were shown a tissue anchor in a baseline

242 (2) In the annotation test (n = 29 nevi), readers were shown a tissue anchor in a follow-up

243 h arrest can be overcome and how melanocytic nevi relate to melanoma are also considered.

244 h those from young, and in human melanocytic nevi relative to normal skin.

245 nt with more than one hundred discrete Spitz nevi scattered all over her skin.

246 Five distinct EDI-OCT patterns of choroidal nevi seemed flat on ultrasonography, and many demonstrat

247 d PTEN, were not found among any melanocytic nevi sequenced.

248 nally, melanocytic nevi including dysplastic nevi showed a significantly lower frequency and a differ

249 ls ranged from 2 to 13; the most common were nevi, skin type, freckle density, age, hair color, and s

250 i labeled UDN and morphologically suspicious nevi, specificity of lesion-focused analysis and IPCA, a

251 ed in situ and invasive melanoma, dysplastic nevi, Spitz nevi, atypical nevus syndrome, family histor

252 frequencies: annually for mildly dysplastic nevi, Spitz nevi, or solely family history of melanoma;

253 The reason nevi stop growing, and do not progress to melanoma, is w

254 nt signaling in the formation of melanocytic nevi, suggesting that activated Wnt signaling may be syn

255 ffect of histologic subtype, age, dysplastic nevi syndrome, and associated cancers on mutation rate;

256 g nevi in BRAF inhibitor therapy is correct: Nevi that involute while a patient is undergoing BRAF V6

257 or older, with 1 or more clinically atypical nevi that required short-term monitoring and were access

258 CI, 1.3-3.9); atypical nevus pattern (>/=20 nevi that were >/=2 mm in diameter), plus at least 5 nev

259 t were >/=2 mm in diameter), plus at least 5 nevi that were 5 mm or greater in diameter (OR, 1.8; 95%

260 Among congenital nevi, the risk of melanoma varies by projected size in a

261 py are associated with enlarging melanocytic nevi, their actual growth dynamics remain unknown.

262 In 2 eyes with nevi there was no increased vascularity; in another, fin

263 ting dysplastic nevi from common melanocytic nevi through a molecular lens.

264 melanoma tissues, compared with melanocytic nevi tissues.

265 is known about the association of many total nevi (TN) or atypical nevi (AN) with tumor thickness.

266 creased from 3,749 per 100,000 women without nevi to 4,124 (95% CI = 3,674-4,649) per 100,000 women w

267 eased from 8.48% for women without cutaneous nevi to 8.82% (95% CI, 8.31%-9.33%) for women with 1-5 n

268 xpression levels of miR-579-3p decrease from nevi to stage III/IV melanoma samples and even further i

269 sive increase of GALC expression from common nevi to stage IV human melanoma samples that was paralle

270 ts, who were asked to identify ugly duckling nevi (UDN).

271 anocytes was induced in halo nevi, which are nevi undergoing immune-mediated regression, and is consi

272 atients with a recent diagnosis of choroidal nevi underwent a novel adaptive optical assessment that

273 Nevi underwent standardized RCM imaging at baseline and

274 f our study include self-report of number of nevi using a qualitative scale, and self-reported histor

275 ing of microscopic structures in melanocytic nevi using RCM is feasible.

276 primary cutaneous melanomas and melanocytic nevi vary widely between 4% and 72%.

277 The number of cutaneous nevi was associated with increased risk of breast cancer

278 Number of nevi was collected at inclusion.

279 ased in patient melanoma samples compared to nevi, we investigated the effect of enhanced FOSL1 expre

280 Connective tissue nevi were categorized per anatomic location and size.

281 On OCT, nevi were classified into 5 subtypes: 3.2% were "not vis

282 Phenotypical data on melanocytic nevi were collected from a random sample of 133 members

283 levance: In this study, perianal melanocytic nevi were common and were associated with prominent and

284 Among higher-risk patients, those with many nevi were more likely to have melanoma on the trunk (41%

285 In addition, numerous preexisting nevi were noted to fade in color on the dual regimen.

286 c; from each participant, 3 confirmed benign nevi were randomly selected from the upper and lower bac

287 limitations in this study are that cutaneous nevi were self-counted in our cohort and that the study

288 Melanomas and nevi were split into training and validation sets.

289 tus, diagnosis of melanoma, and excisions of nevi) were collected.

290 xpression in melanocytes was induced in halo nevi, which are nevi undergoing immune-mediated regressi

291 spite this, the vast majority of melanocytic nevi, which typically form as a result of BRAF(V600E)-ac

292 Importance: Although nevi with a peripheral rim of globules (peripheral globu

293 ep in melanoma progression from nonmalignant nevi with BRAF mutations.

294 , which typically lead to benign melanocytic nevi with characteristic histologic features.

295 is the association of pigmented melanocytic nevi with extra-cutaneous features, classically melanoti

296 Associations of number of nevi with personal history of benign breast disease (BBD

297 distinguishes between melanoma and atypical nevi with sensitivity of 100% and specificity of 90.9%.

298 Imaging of choroidal nevi with SS-OCT enables visualization of intralesional

299 nevi without dysplastic changes, dysplastic nevi with structural and architectural atypia, and melan

300 cytic nevi at three different stages: common nevi without dysplastic changes, dysplastic nevi with st

301 Compared to women with no nevi, women with more cutaneous nevi had higher risks of